Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Epirus Biopharmaceuticals Inc
EPRSQ
Healthcare
Biotechnology
EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:EPRSQ)
New Post
View:
Posts & Comments
Threaded Posts
(4)
•••
zalmonella
X
View Profile
View Bullboard History
Comment by
zalmonella
on Jun 22, 2016 1:00pm
RE:Am I the only one ?
No, you're not the only one. I've been in and out a couple of times as Zalicus and now I'm back in as EPRS - but underwater. Good thing thjis is only a tiny flyer. They're
...more
(0)
•••
AkaJoeBoo
X
View Profile
View Bullboard History
Post by
AkaJoeBoo
on Apr 04, 2016 6:27pm
Am I the only one ?
The only one following this company ? Or is there other like me stuck with those Zalicus shares ?! Well, would be nice to have some action on this forum. Hope this goes back to 12$ :D
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(0)
•••
dollarbags23
X
View Profile
View Bullboard History
Post by
dollarbags23
on Nov 11, 2013 10:15pm
What's up with Zalicus??
Crushed my hopes and dreams today. Though may be looking to buy more. Kind of disappointing for the biotech believers out there like myself. Full Article on Tickrwatch
(2)
•••
jakethesnake2
X
View Profile
View Bullboard History
Post by
jakethesnake2
on Sep 27, 2013 11:35am
Zalicus approved for Orphan Drug Status
FYI The big SP increase today is due to the announcement of the Orphan drug status. Regards Jack
(0)
•••
clementsgayle
X
View Profile
View Bullboard History
Post by
clementsgayle
on Dec 18, 2012 10:35am
Turn ZLCS Into Your Personal ATM!
I have been hearing that there could be a huge IR campaign taking off for ZLCS in the near future. I have been holding this stock for a long time and this may be the boost we need. https
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden